Ceftriaxone, a β-lactam antibiotic, exerts strong neuroprotective effects by increasing EAAT2 expression to prevent glutamate neurotoxicity62,63 and is in clinical trials for neurological disorders such as Parkinson’s disease64. Here, SLC1A2 is linked to nervous system disorder.